Yuhan gets USD 30 Million from J&J as Lazcluze-Rybrevant reaches Europe
Yuhan Corporation announced that it will receive a $30 million milestone payment from Johnson & Johnson following the European commercial launch of lazertinib (Korean brand
Yuhan Corporation announced that it will receive a $30 million milestone payment from Johnson & Johnson following the European commercial launch of lazertinib (Korean brand
Part-time Operations Associate/Executive Assistant Yuhan USA Corporation Work locations: Cambridge, MA Employee type: part-time Contact Information: info@yuhan-usa.com Yuhan USA Corporation is seeking a highly motivated